Allotment of Securities

Date: 03rd July, 2026 National Stock Exchange of India Ltd., Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051. Stock Code: VAISHALI Sub: Allotment of 45,37,865 equity shares at an issue price of Rs. 20 per share on a Preferential Basis. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and further to the outcome of the Board Meeting held on 13th February, 2026 and the approval of the shareholders by way of Special Resolution passed through Postal Ballot on 15th March, 2026 for issuance of equity shares on a preferential basis for consideration other than cash, we wish to inform you that the Board of Directors of the Company, by way of resolution passed through circulation today, i.e., 03rd July, 2026, has approved the allotment of 45,37,865 (Forty-Five Lakh Thirty-Seven Thousand Eight Hundred Sixty-Five) fully paid-up equity shares of face value of Rs. 2/- each at an issue price of Rs. 20/- per equity share (including a premium of Rs. 18/- per equity share), aggregating to Rs. 9,07,57,300/-, to Kesar Pharma Limited ("KPL") on a preferential basis for consideration other than cash, by way of swap of equity shares pursuant to the acquisition of 26.95% shareholding in KPL. Consequent to the aforesaid allotment, the paid-up equity share capital of the Company has increased from Rs. 26,09,24,260/- comprising 13,04,62,130 equity shares of Rs. 2/- each to Rs. 26,99,99,990/- comprising 13,49,99,995 equity shares of Rs. 2/- each. The aforesaid allotment has been made pursuant to the shareholders' approval and the In- Principle Approval received from the National Stock Exchange of India Limited vide Letter No. NSE/LIST/53490 dated 24th June, 2026. The Company shall file an application to the stock exchanges for listing and trading approval for the newly allotted shares in due course. The details required pursuant to Regulation 30 of the Listing Regulations read with Clause A(2)(2.1) of Annexure 18 of SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024 (“Disclosure Circular”), are enclosed hereto as Annexure – A. Kindly take the above on record. Thanking You, Yours Faithfully, For Vaishali Pharma Limited Vishwa Mekhia Company Secretary Cum Compliance Officer Annexure - A The details as required under Regulation 30 of the Listing Regulations read with Clause A(2)(2.1) of Annexure 18 of the Disclosure Circular Sr. Particulars Details 1. Type of securities Equity shares of face value Rs. 2 (Rupee Two) each. proposed to be issued (viz. equity shares, convertibles etc.) 2. Type of issuance Preferential issue of equity shares in accordance with the Securities (further public and Exchange Board of India (Issue of Capital and Disclosure offering, rights Requirements) Regulations, 2018 (“ICDR Regulations”), read with issue, depository the Companies Act, 2013 and rules made thereunder. receipts (ADR/GDR), qualified institutions placement, preferential allotment etc.) 3. Total number of Allotment of 45,37,865 (Forty-Five Lakh Thirty-Seven Thousand Eight Hundred Sixty Five Only) equity shares of the Company securities proposed having face value of Rs. 2 (Rupee Two) each, which is not less than to be issued or the the price determined in accordance with Chapter V of the ICDR total amount for Regulations, for consideration other than cash, as discharge of the which the securities non-cash consideration for the subscription of 26.95% of the will be issued proposed total issued, subscribed and paid-up equity share capital (approximately) of Kesar Pharma Limited (“KPL”) 4. Additional details: (a) Name of the Kesar Pharma Limited investor Sr. Name of the Allottee Category No. of Equity No. (Promoter/ Shares Non- allotted Promoter) 1. Kesar Pharma Limited Non- 45,37,865 Promoter Sr. Particulars Details (b) Post Allotment of Equity Shares (i) Outcome of Details of the Shareholding and voting rights of the allottees are as Subscription under: Name of Pre Preferential No. of Post Preferential the Shareholding Equity Shareholding Allottee No. of % Shares No. of % Shares allotted Shares Kesar Nil Nil 45,37,865 45,37,865 3.36 % Pharma Limited (ii) Issue Price/ Issue price of Rs. 20/- each (Face Value Rs.2/- each + Premium Rs. Allotted Price 18/- each). (iii) Number of Investors 1 (One) (c) In case of Not applicable convertibles - Intimation on conversion of securities or on lapse of the tenure of the instrument 5. Any cancellation or Not applicable termination of proposal for issuance of securities including reasons thereof ****